A high homocysteine, low folate phenotype is a feature of many diseases. The effect of the cystathionine b-synthase (CBS) 844ins68 polymorphism on homocysteine and folate concentrations was examined alone and in the context of the 5,10-methylenetetrahydrofolate reductase (MTHFR) 677C4T polymorphism in a Northwestern European male population. The MTHFR 677TT genotype is known to be associated with increased homocysteine and decreased folate relative to CT heterozygotes and CC homozygotes in this and other populations. MTHFR 677TT homozygotes who were also CBS 844ins68 carriers had homocysteine and folate concentrations similar to those of individuals with the MTHFR 677CT and CC genotypes. Homocysteine levels in MTHFR 677TT subjects carrying the CBS 844ins68 allele were 24.1% lower than in non-carriers (6.66 vs 8.77 lmol/l, P ¼ 0.045), and serum folate levels were 27.7% higher (11.16 vs 8.74 nmol/l, P ¼ 0.034). These findings suggest that the CBS 844ins68 allele 'normalizes' homocysteine and folate levels in MTHFR 677TT individuals.
Introduction
The folate/homocysteine metabolic pathway provides onecarbon units for important biological functions, such as methylation of DNA and proteins, and support of thymidylate and purine synthesis. A phenotype characterized by high homocysteine and low folate may be pathogenic and has been associated with diverse conditions ranging from cardiovascular diseases 1 to birth defects including spina bifida. 2 Homocysteine concentrations are influenced by dietary factors such as folate and B vitamins, lifestyle factors such as smoking, and genetic factors such as functional polymorphisms in the enzymes of folate/ homocysteine metabolism. 3 The key enzyme 5,10-methylenetetrahydrofolate reductase (MTHFR, EC 1.5.1.20) generates 5-methyltetrahydrofolate, the methyl donor that is used for homocysteine remethylation to methionine. Cystathionine b-synthase (CBS, EC 4.2.1.22) is a central enzyme in the transsulfuration pathway that irreversibly metabolizes homocysteine to cystathionine. Individuals homozygous for loss-offunction mutations in either of these genes have homocystinuria, characterized by extremely high homocysteine concentrations. Mildly dysfunctional variants of MTHFR have a more modest, but significant, effect on homocysteine concentration and are associated with hyperhomocysteinemia. The most widely studied functional variant is the MTHFR 677C4T (A222V; dbSNP rs1801133) polymorphism, the T allele of which encodes a thermolabile product with mildly impaired activity. 4 MTHFR 677TT
homozygotes are more likely than those with the CT or CC genotypes to have hyperhomocysteinemia, especially under low folate conditions. 5, 6 The CBS 844ins68 allele contains an insertion of 68 bp in exon 8 677TT homozygotes who carry a CBS 844ins68 allele had lower homocysteine levels (similar to those observed in MTHFR 677 CT or CC subjects) than noncarriers; however, folate levels were not presented in this report. More recently Dekou et al 10 also reported that the CBS 844ins68 allele appears to have a homocysteine lowering effect in MTHFR 677TT homozygotes, but again no data were reported for the effect on folate levels. The study described here was designed to determine whether the CBS 844ins68 allele, alone or in the context of MTHFR 677C4T genotype, has an impact on folate as well as homocysteine concentrations.
Subjects and methods
Subjects (n ¼ 614) were drawn from the 'Industrial Workers Study' comprising men aged 29 -53 years who at the time of recruitment worked for an industrial company in Belfast, Northern Ireland. 5, 11 The study was approved by the Research Ethics Committee of the Faculty of Medicine, The Queen's University of Belfast. All subjects provided written informed consent before participation. None of the participants had diabetes and none were taking nutritional supplements. Blood samples were collected from fasting subjects for determination of biochemical parameters and DNA extraction. Total homocysteine concentrations were determined previously 5 using an established high-performance liquid chromatography method, 12 and serum folate concentrations were determined previously using a commercial kit (ICN Pharmaceuticals). MTHFR 677C4T genotyping was RFLP based, 4 and genotypes for the study population have previously been reported. 5 CBS 844ins68 genotypes were obtained using a published PCR-based size difference method. 13 Statistical analyses were performed with SAS version 9.1. Even after logarithmic transformation, distributions of homocysteine and serum folate were positively skewed, so all analyses were performed using untransformed data. HardyWeinberg equilibrium for the MTHFR 677C4T and CBS 844ins68 genotypes were assessed by the w 2 -test. Differences between groups for homocysteine and serum folate were assessed using the Wilcoxon rank-sum or KruskalWallis test.
Results
The MTHFR 677C4T and CBS 844ins68 genotype frequencies were both in Hardy -Weinberg equilibrium (P ¼ 0. 923 and P ¼ 0.153, respectively). Frequencies of the former (45% CC, 43.6% CT and 11.4% TT) have been previously reported. 5 Genotype frequencies for the latter, together with homocysteine and serum folate concentrations are presented in Table 1 . As previously reported, 5 MTHFR 677TT homozygotes have markedly higher homocysteine and substantially lower folate concentrations than those with the CT and CC genotypes. As depicted in Figure 1 , genotype-specific homocysteine values are 8.55, 7.33, and 6.81 mmol/l, Figure 2 , the genotype-specific serum folate values for these three genotypes are 8.97, 10.93, and 11.50 nmol/l, respectively (Po0.0001 by Kruskal -Wallis).
In the study population as a whole, CBS 844ins68 carriers have marginally lower homocysteine levels and marginally higher folate levels compared to noncarriers, but these modest differences are not statistically significant (Table 1) . When considered in the context of each of the MTHFR 677C4T genotypes, CBS 844ins68 carrier status has no significant impact on homocysteine or folate levels in either MTHFR 677CT heterozygotes or CC homozygotes (Figures 1 and 2 ), but in MTHFR 677TT homozygotes it was associated with 24.1% lower homocysteine (6.66 vs 8.77 mmol/l, P ¼ 0.045) and 27.7% higher folate (11.16 vs 8.74 nmol/l, P ¼ 0.034). The CBS 844ins68 allele appears to 'counterbalance' the homocysteine-raising and folate-lowering effect of the TT genotype such that TT/844ins68 carriers have homocysteine and folate concentrations that are similar to those of MTHFR 677CT heterozygotes or CC homozygotes.
Discussion
The MTHFR 677C4T polymorphism has a major impact on homocysteine levels in populations with a large proportion of individuals with low folate status 14 including the cohort reported here. Dekou et al 10 and Fredriksen et al 15 have
both reported that CBS 844ins68 carriers have fasting homocysteine levels that are modestly but significantly lower than those of noncarriers, although others have found no statistically significant difference in homocysteine levels between carriers and noncarriers. 16 -19 Interestingly, some studies in which carrier status did not influence fasting homocysteine found that after methionine loading, used experimentally to raise homocysteine concentrations and induce the CBS-mediated transsulfuration pathway, the CBS 844ins68 allele is associated with decreased homocysteine levels. 20 -22 Although the exact mechanism by which the 844ins68 allele affects CBS function is currently unknown, it may mandate an increase in CBS activity, possibly via up-regulation of the amount of CBS mRNA or though the action of another functional polymorphism with which it is in linkage disequilibrium. 20 Others have reported effects attributable to the 699C4T and 1080C4T polymorphisms; however, these are both silent changes that themselves are unlikely to have a direct effect indicating the possibility of linkage disequilibrium with as yet unknown transcriptional control elements. 15, 23 Two reports, a European-wide study 9 and a subsequent study from the United Kingdom, 10 have suggested that the CBS 844ins68 allele may counterbalance the homocysteine-raising effect of the MTHFR 677TT genotype, although these findings were not replicated in a subsequent UK study. 19 Our results, derived from a Northern Irish sample, support the reports that homocysteine levels in MTHFR 677TT homozygotes who carry the CBS 844ins68 allele are significantly lower than in those who do not. In addition, we have made the novel observation that the subset of the MTHFR 677TT genotype class that are CBS 844ins68 carriers (ie 15% of MTHFR 677TT homozygotes) have significantly higher serum folate concentrations than noncarriers. Our results may therefore have important implications for a range of conditions, such as cardiovascular disease and spina bifida in which high homocysteine and low folate each appear to be a contributing feature. The excess risk for such conditions conferred by MTHFR 677TT homozygosity may be negated, at least in part, by CBS 844ins68 carrier status. This hypothesis will be testable in future disease association studies that are large enough to have sufficient power to examine gene -gene interactions.
In conclusion, the CBS 844ins68 allele itself has no statistically significant impact on homocysteine or folate concentrations in a healthy Northwestern European male population. However, it appears to counterbalance the homocysteine-raising and folate-lowering effects of the MTHFR 677TT genotype such that the concentrations of these biochemical variables are essentially the same as those observed in MTHFR 677CT or CC individuals. Thus, the CBS 844ins68 allele may ameliorate the excess risk associated with a high homocysteine and low folate phenotype to which MTHFR 677TT homozygotes would otherwise be predisposed, thereby favorably modifying the risk of pathologies attributable to this MTHFR genotypic class.
